In endothelial cells, evidence showed that S1PR1 signaling is more dependent on HDL-bound S1P compared to albumin-bound S1P for their downstream activation of Akt and eNOS [9,127], which are known targets for cancer treatment. This evidence concerns the gene S1PR1 and cancer.